Clinical Trial Update: EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Enterogermina (Bacillus clausii) for irritable bowel syndrome with suspected small intestinal bacterial overgrowth. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Small Intestinal Bacterial Overgrowth

Drugs mentioned

• Enterogermina (Bacillus clausii)

Snippet

Sponsor: Sanofi | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED